Eckert & Ziegler Awards Grants to Young Scientists in Nuclear Medicine

Berlin, 31 October 2012. This year’s Travel Grants – presented by Eckert & Ziegler Strahlen- und Medizintechnik AG – were awarded to five nuclear medicine scientists from Italy, Switzerland, and the USA. The awards for research work in the fields of oncological diagnostics and therapy and cardiovascular diagnostics were distributed at the Congress of the European Association of Nuclear Medicine (EANM) in Milan.

The competition, which was sponsored by Eckert & Ziegler AG in collaboration with the European Association of Nuclear Medicine (EANM) and offered EUR 1,000 in prize money to each recipient, was held for the fifth time.

The seven-man EANM jury selected the following laureates from among a total of 563 entries:

R. Assante, Italy: Prediction of Severe Coronary Artery Disease in Diabetic Patients with Gated SPECT Myocardial Perfusion Imaging

W. Cai, USA: In Vivo Targeting and Imaging of Tumor Vasculature with Radio-Labeled, Antibody-Conjugated Nano-Graphene

E. Deshayes, Switzerland: Myocardial Flow Reserve by Rb-82 Cardiac PET Improves the Selection of Patients Eligible for Invasive Coronary Angiography

E. Lopci, Italy: Additional Role of FDG PET in Pediatric HD Patients Presenting with a Partial Response on CT: Data Deriving from a Multi-Centric Italian Study

M. Walter, Switzerland: Somatostatin-based Radiotherapy with [90Y-DOTA]-TOC in Neuroendocrine Tumors: Long-Term Outcome of a Phase I Dose Escalation Study

“Nuclear medical imaging gives an enormous impetus to personalized medicine. It makes a valuable contribution to controlling the therapeutic process. With it, alternative therapeutic concepts can be offered to patients who do not respond to a certain form of treatment,” said Dr. André Heß, member of the Executive Board of Eckert & Ziegler and responsible for the Radiopharma Segment.

With its Travel Award, Eckert & Ziegler assists young scientists in making their research results in the field of medical imaging available to a broad public.

With more than 600 employees worldwide, Eckert & Ziegler AG (ISIN DE0005659700), Berlin, is one of the largest suppliers of radioactive components for radiation therapy and nuclear medicine.

Further information about the Eckert & Ziegler Travel Award can be found at http://www.ezag.com/home/about-us/social-engagement/abstract-award.html

Your contact person for inquiries is:

Eckert & Ziegler AG
Karolin Riehle, Investor Relations & PR, Robert-Rössle-Str. 10, D-13125 Berlin
Tel.: +49 (0) 30 / 941084-138, Fax-112, E-Mail: karolin.riehle@dont-want-spam.ezag.de, www.ezag.de